Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension
NCT02238275
·
clinicaltrials.gov ↗
COMPLETED
Status
8135
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
Micardis® plus
Sponsor
Boehringer Ingelheim